Group One Trading’s PDS Biotechnology PDSB Stock Holding History

Group One Trading’s Portfolio PDSB Stock Details PDSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$1.91K	–	7794
2024 Q3	$1.91K	Sell	500 -13,200	-96%	-$44K	﹤0.01%	6157
2024 Q2	$40.1K	Sell	13,700 -9,600	-41%	-$30.7K	﹤0.01%	4685
2024 Q1	$92.3K	Sell	23,300 -38,500	-62%	-$198K	﹤0.01%	4221
2023 Q4	$307K	Buy	61,800 +52,100	+537%	+$259K	﹤0.01%	3486
2023 Q3	$49K	Sell	9,700 -11,900	-55%	-$65.2K	﹤0.01%	5114
2023 Q2	$109K	Buy	21,600 +19,600	+980%	+$128K	﹤0.01%	4528
2023 Q1	$12.3K	Sell	2,000 -500	-20%	-$4.09K	﹤0.01%	5822
2022 Q4	$33K	Buy	+2,500	New	+$17.6K	﹤0.01%	5278
2021 Q3	–	Sell	-400	Closed	-$5K	–	8632
2021 Q2	$5K	Buy	+400	New	+$3.12K	﹤0.01%	7772

Other funds holding PDSB

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's PDSB Position: Q1 2026 in Review

Group One Trading reduced its PDS Biotechnology (PDSB) stake by 9.1% in Q1 2026, selling an estimated $267 and leaving 3,567 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #7028.

Group One Trading first reported a position in PDSB in Q1 2018 and has held it in 27 quarters since. The position peaked at $264K in Q4 2023. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

Group One Trading held 3,567 shares of PDS Biotechnology worth $2.16K as of Q1 2026.
Group One Trading sold 355 PDS Biotechnology shares in Q1 2026, an estimated $267.
PDS Biotechnology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7028 holding.
Group One Trading first reported a position in PDS Biotechnology in Q1 2018 and has held it in 27 quarters since.
Group One Trading's PDS Biotechnology position peaked at $264K in Q4 2023.
41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.